8-K filed November 12, 2024, 6:59 PM ET ticker HQY CIK 0001428336

leadership confidence high sentiment neutral materiality 0.65

HealthEquity CEO Jon Kessler to retire Jan 6, 2025; Scott Cutler appointed as successor

HEALTHEQUITY, INC.

CEO Jon Kessler to retire effective Jan 6, 2025, serve as Special Advisor through Apr 30, 2025.
Scott Cutler appointed President & CEO and director effective Jan 6, 2025.
Cutler was CEO of StockX, SVP Americas at eBay, President of StubHub, EVP of NYSE Euronext.
Cutler receives base salary $775k, sign-on bonus $650k, and RSU award with fair value $7.5M vesting over 3 years.
Kessler transition includes extended non-compete to three years after termination and PRSU treatment.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Scott R. Cutler

President and Chief Executive Officer

HQY · HEALTHEQUITY, INC.

Effective: 2025-01-06
Filed: November 12, 2024, 6:59 PM ET

the Board approved the appointment of Scott R. Cutler as President and Chief Executive Officer, effective as of January 6, 2025

Departed

Jon Kessler

member of the Board of Directors

HQY · HEALTHEQUITY, INC.

Effective: 2025-04-30
Filed: November 12, 2024, 6:59 PM ET

will retire from his employment with the Company, effective January 6, 2025, and from the Board, effective April 30, 2025

Appointed

Scott R. Cutler

Director

HQY · HEALTHEQUITY, INC.

Effective: 2025-01-06
Filed: November 12, 2024, 6:59 PM ET

the Board also expanded the size of the Board to eleven directors and appointed Mr. Cutler to fill the vacancy created by the increased size of the Board, each effective as of the Commencement Date

Departed

Jon Kessler

President & Chief Executive Officer

HQY · HEALTHEQUITY, INC.

Effective: 2025-01-06
Successor: Scott R. Cutler
Filed: November 12, 2024, 6:59 PM ET

Jon Kessler, President & Chief Executive Officer of the Company and a member of the Board of Directors (the “Board”), will retire from his employment with the Company, effective January 6, 2025

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Scott R. Cutler was appointed as President and Chief Executive Officer at HEALTHEQUITY, INC..

Action: appointed
Role: President and Chief Executive Officer

Exact text from the filing

the Board approved the appointment of Scott R. Cutler as President and Chief Executive Officer, effective as of January 6, 2025

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Jon Kessler departed as member of the Board of Directors at HEALTHEQUITY, INC..

Action: retire
Role: member of the Board of Directors

Exact text from the filing

will retire from his employment with the Company, effective January 6, 2025, and from the Board, effective April 30, 2025

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Scott R. Cutler was appointed as Director at HEALTHEQUITY, INC..

Action: appointed
Role: Director

Exact text from the filing

the Board also expanded the size of the Board to eleven directors and appointed Mr. Cutler to fill the vacancy created by the increased size of the Board, each effective as of the Commencement Date

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Jon Kessler departed as President & Chief Executive Officer at HEALTHEQUITY, INC..

Action: retire
Role: President & Chief Executive Officer

Exact text from the filing

Jon Kessler, President & Chief Executive Officer of the Company and a member of the Board of Directors (the “Board”), will retire from his employment with the Company, effective January 6, 2025

View on SEC.gov

HEALTHEQUITY, INC. filing history →

Source: SEC EDGAR

accession 0001428336-24-000104

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.